A double blind randomised placebo controlled phase III trial in patients with chronic idiopathic constipation to demonstrate the efficacy and safety of Elobixibat 5mgs & 10mgs for 26 wks (ECHO)

1st September 2013

Status: Ended

Specialism: Lower GI.

Team: Professor Robin Spiller.

Photo Name Bio
professor-robin-spiller Professor Robin Spiller Professor Spiller is Professor of Gastroenterology in the NIHR Nottingham Biomedical Research Centre at the University of Nottingham. Past Editor of Gut (2003-2009) and member of the Board of the Rome Foundation (2000-2015), he twice edited the…
Title Amount